Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

NCT04743791 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab
OTHER: Placebo

Sponsor

Sally E. Wenzel MD